Merck Company Stock Z Score

MRK Stock  USD 131.75  6.23  4.96%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Merck Piotroski F Score and Merck Valuation analysis.
  
At this time, Merck's Additional Paid In Capital is quite stable compared to the past year. Long Term Debt To Capitalization is expected to rise to 0.50 this year, although the value of Net Working Capital will most likely fall to about 6.3 B. At this time, Merck's Total Operating Expenses is quite stable compared to the past year. Income Tax Expense is expected to rise to about 2 B this year, although the value of Operating Income will most likely fall to about 2.8 B.

Merck Z Score Analysis

Merck's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

Current Merck Z Score

    
  6.81  
Most of Merck's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck Company is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Merck Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Merck is extremely important. It helps to project a fair market value of Merck Stock properly, considering its historical fundamentals such as Z Score. Since Merck's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Merck's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Merck's interrelated accounts and indicators.
0.720.870.280.880.610.590.150.70.980.30.80.490.160.950.420.750.730.65-0.260.44-0.21-0.220.190.350.220.360.31-0.70.020.190.20.150.2
0.720.420.780.90.840.89-0.460.960.670.30.40.82-0.10.780.530.790.830.83-0.80.560.22-0.610.510.670.39-0.02-0.12-0.780.310.480.410.07-0.25
0.870.42-0.070.590.430.360.570.40.90.080.930.050.370.720.120.420.360.220.180.21-0.260.23-0.07-0.020.10.610.48-0.48-0.37-0.070.160.350.2
0.280.78-0.070.570.750.84-0.730.830.180.11-0.090.73-0.20.420.450.680.740.71-0.860.50.52-0.580.540.820.58-0.42-0.26-0.430.320.560.48-0.1-0.59
0.880.90.590.570.690.76-0.310.830.840.260.50.80.010.90.480.820.910.89-0.650.580.03-0.480.370.650.370.040.04-0.740.240.480.370.180.08
0.610.840.430.750.690.93-0.290.910.570.130.470.6-0.280.630.290.730.680.57-0.60.710.5-0.350.510.60.680.08-0.26-0.590.010.580.60.16-0.6
0.590.890.360.840.760.93-0.430.920.540.130.340.69-0.190.60.250.790.780.65-0.720.690.54-0.340.450.740.68-0.13-0.19-0.650.070.610.670.21-0.54
0.15-0.460.57-0.73-0.31-0.29-0.43-0.420.23-0.120.57-0.740.46-0.03-0.3-0.35-0.49-0.610.9-0.37-0.460.72-0.46-0.71-0.330.710.560.2-0.61-0.6-0.280.170.3
0.70.960.40.830.830.910.92-0.420.640.350.40.75-0.170.780.550.830.810.78-0.760.560.25-0.590.520.650.45-0.05-0.09-0.750.280.460.38-0.03-0.39
0.980.670.90.180.840.570.540.230.640.310.820.40.210.910.30.670.640.55-0.180.4-0.25-0.120.150.240.180.380.33-0.71-0.060.180.160.190.21
0.30.30.080.110.260.130.13-0.120.350.310.120.3-0.270.410.30.320.130.26-0.250.03-0.44-0.470.19-0.13-0.35-0.040.1-0.630.73-0.13-0.43-0.630.2
0.80.40.93-0.090.50.470.340.570.40.820.120.070.150.650.150.420.290.160.190.28-0.210.14-0.05-0.050.110.750.25-0.47-0.31-0.090.140.220.14
0.490.820.050.730.80.60.69-0.740.750.40.30.07-0.370.580.450.790.850.9-0.90.630.25-0.750.440.80.38-0.33-0.39-0.650.570.580.39-0.09-0.04
0.16-0.10.37-0.20.01-0.28-0.190.46-0.170.21-0.270.15-0.370.140.06-0.26-0.11-0.140.37-0.55-0.480.36-0.28-0.27-0.350.220.770.11-0.4-0.48-0.30.080.28
0.950.780.720.420.90.630.6-0.030.780.910.410.650.580.140.590.740.770.76-0.410.38-0.27-0.430.30.380.190.240.29-0.70.210.230.06-0.030.13
0.420.530.120.450.480.290.25-0.30.550.30.30.150.450.060.590.370.480.68-0.48-0.09-0.32-0.760.420.29-0.160.120.17-0.220.51-0.05-0.27-0.330.09
0.750.790.420.680.820.730.79-0.350.830.670.320.420.79-0.260.740.370.910.79-0.630.680.23-0.410.380.750.51-0.14-0.08-0.710.240.440.490.01-0.09
0.730.830.360.740.910.680.78-0.490.810.640.130.290.85-0.110.770.480.910.93-0.730.670.23-0.520.410.880.56-0.2-0.09-0.580.240.60.490.11-0.06
0.650.830.220.710.890.570.65-0.610.780.550.260.160.9-0.140.760.680.790.93-0.820.510.07-0.750.50.790.33-0.2-0.1-0.560.490.510.28-0.020.07
-0.26-0.80.18-0.86-0.65-0.6-0.720.9-0.76-0.18-0.250.19-0.90.37-0.41-0.48-0.63-0.73-0.82-0.5-0.40.79-0.56-0.79-0.380.510.410.54-0.57-0.61-0.370.070.3
0.440.560.210.50.580.710.69-0.370.560.40.030.280.63-0.550.38-0.090.680.670.51-0.50.61-0.230.390.710.84-0.05-0.6-0.410.040.850.750.24-0.33
-0.210.22-0.260.520.030.50.54-0.460.25-0.25-0.44-0.210.25-0.48-0.27-0.320.230.230.07-0.40.610.070.280.580.81-0.33-0.650.07-0.250.660.850.43-0.74
-0.22-0.610.23-0.58-0.48-0.35-0.340.72-0.59-0.12-0.470.14-0.750.36-0.43-0.76-0.41-0.52-0.750.79-0.230.07-0.51-0.460.020.230.330.4-0.82-0.310.140.450.03
0.190.51-0.070.540.370.510.45-0.460.520.150.19-0.050.44-0.280.30.420.380.410.5-0.560.390.28-0.510.430.310.0-0.35-0.30.250.410.25-0.04-0.3
0.350.67-0.020.820.650.60.74-0.710.650.24-0.13-0.050.8-0.270.380.290.750.880.79-0.790.710.58-0.460.430.72-0.42-0.38-0.310.180.740.690.18-0.3
0.220.390.10.580.370.680.68-0.330.450.18-0.350.110.38-0.350.19-0.160.510.560.33-0.380.840.810.020.310.72-0.14-0.47-0.08-0.290.820.840.39-0.62
0.36-0.020.61-0.420.040.08-0.130.71-0.050.38-0.040.75-0.330.220.240.12-0.14-0.2-0.20.51-0.05-0.330.230.0-0.42-0.140.150.01-0.33-0.33-0.140.080.19
0.31-0.120.48-0.260.04-0.26-0.190.56-0.090.330.10.25-0.390.770.290.17-0.08-0.09-0.10.41-0.6-0.650.33-0.35-0.38-0.470.15-0.03-0.22-0.6-0.430.010.37
-0.7-0.78-0.48-0.43-0.74-0.59-0.650.2-0.75-0.71-0.63-0.47-0.650.11-0.7-0.22-0.71-0.58-0.560.54-0.410.070.4-0.3-0.31-0.080.01-0.03-0.35-0.17-0.150.12-0.03
0.020.31-0.370.320.240.010.07-0.610.28-0.060.73-0.310.57-0.40.210.510.240.240.49-0.570.04-0.25-0.820.250.18-0.29-0.33-0.22-0.350.07-0.34-0.650.2
0.190.48-0.070.560.480.580.61-0.60.460.18-0.13-0.090.58-0.480.23-0.050.440.60.51-0.610.850.66-0.310.410.740.82-0.33-0.6-0.170.070.670.34-0.44
0.20.410.160.480.370.60.67-0.280.380.16-0.430.140.39-0.30.06-0.270.490.490.28-0.370.750.850.140.250.690.84-0.14-0.43-0.15-0.340.670.64-0.46
0.150.070.35-0.10.180.160.210.17-0.030.19-0.630.22-0.090.08-0.03-0.330.010.11-0.020.070.240.430.45-0.040.180.390.080.010.12-0.650.340.64-0.07
0.2-0.250.2-0.590.08-0.6-0.540.3-0.390.210.20.14-0.040.280.130.09-0.09-0.060.070.3-0.33-0.740.03-0.3-0.3-0.620.190.37-0.030.2-0.44-0.46-0.07
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

Based on the company's disclosures, Merck Company has a Z Score of 6.81. This indicator is about the same for the Pharmaceuticals average (which is currently at 6.75) sector and significantly higher than that of the Health Care industry. The z score for all United States stocks is 21.9% higher than that of the company.

Merck Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merck's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merck could also be used in its relative valuation, which is a method of valuing Merck by comparing valuation metrics of similar companies.
Merck is currently under evaluation in z score category among related companies.

Merck ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Merck's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Merck's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Merck Institutional Holders

Institutional Holdings refers to the ownership stake in Merck that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Merck's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Merck's value.
Shares
Northern Trust Corp2023-12-31
28.5 M
Jpmorgan Chase & Co2023-12-31
25.4 M
Goldman Sachs Group Inc2023-12-31
24.2 M
Legal & General Group Plc2023-12-31
23.5 M
Deutsche Bank Ag2023-12-31
21.6 M
Bank Of New York Mellon Corp2023-12-31
20.8 M
Amvescap Plc.2023-12-31
16.8 M
Nuveen Asset Management, Llc2023-12-31
16.7 M
Ameriprise Financial Inc2023-12-31
16.4 M
Vanguard Group Inc2023-12-31
244.8 M
Blackrock Inc2023-12-31
201.8 M

Merck Fundamentals

About Merck Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Merck Company's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Company based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 67000 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.453
Dividend Share
2.92
Earnings Share
0.14
Revenue Per Share
23.695
Quarterly Revenue Growth
0.058
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.